Important Notice: Our clinic will be closed on January 1 in observance of the New Year.
We wish you a prosperous and healthy New Year. Thank you for your understanding.
SPRAVATO® for TRD (Treatment-Resistant Depression)
FDA-Approved for TRD: SPRAVATO® is the only nasal spray approved by the FDA for treatment-resistant depression (TRD).
NMDA Receptor Antagonist: SPRAVATO® acts on the brain's glutamate pathway via NMDA receptor antagonism, though the exact mechanism is not fully understood.
Nasal Spray Device: SPRAVATO® is administered through a nasal spray.